Literature DB >> 1393165

Representations of health, illness and medicines: coping strategies and health-promoting behaviour.

A Echebarría Echabe1, C Sanjuan Guillen, J Agustín Ozamiz.   

Abstract

This study focuses on the different representations of health, illness and medicines that are held by the population of the Basque Country. In addition, relationships between these representations and both coping strategies towards first symptoms of disease and health-promoting actions were studied. Three different representations were found: (a) an active/'against medicines' representation; (b) a 'magical/pro-medicines' representation; and (c) a representation that combines aspects of the previous representations. These representations were anchored in different social groups (defined by age, educational background, etc.) and were related to different coping strategies in the event of first symptoms of illness, and to differences in health-promoting behaviour.

Mesh:

Year:  1992        PMID: 1393165     DOI: 10.1111/j.2044-8260.1992.tb01003.x

Source DB:  PubMed          Journal:  Br J Clin Psychol        ISSN: 0144-6657


  3 in total

1.  Do patients think cannabis causes schizophrenia? - A qualitative study on the causal beliefs of cannabis using patients with schizophrenia.

Authors:  Anna Buadze; Rudolf Stohler; Beate Schulze; Michael Schaub; Michael Liebrenz
Journal:  Harm Reduct J       Date:  2010-09-28

2.  Adult attention-deficit/hyperactivity disorder and nicotine use: a qualitative study of patient perceptions.

Authors:  Michael Liebrenz; Anja Frei; Carl Erik Fisher; Alex Gamma; Anna Buadze; Dominique Eich
Journal:  BMC Psychiatry       Date:  2014-05-16       Impact factor: 3.630

3.  Adult attention-deficit/hyperactivity disorder and nicotine withdrawal: a qualitative study of patient perceptions.

Authors:  Michael Liebrenz; Carl Erik Fisher; Romilda Nellen; Anja Frei; Anne-Catherine Biechl; Nina Hiestand; Alice Huber; Anna Buadze; Dominique Eich
Journal:  BMC Psychiatry       Date:  2016-07-04       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.